![]() Pulmatrix Pulmatrix develops inhaled therapies for the treatment, prevention, and transmission of infectious and progressive respiratory diseases. | |||
Founding Date | Founding Date 2003 | Founding Date 1929 | Founding Date 1904 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Lexington, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 228% decrease | Employees 5,358 | Employees 7,5692% decrease |
Valuation ($) | Valuation ($) 8 m | Valuation ($) 10.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) |
Gross profit | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit $4.5b (FY, 2020) |
Net income | Net income ($5.2m) (FY, 2025) | Net income €445.1m (FY, 2025) | Net income N/A |